CRM1

CRM1 Products

  • All (7)
  • CRM1 Inhibitors (7)
  • New CRM1 Products
Catalog No. Product Name Information Product Use Citations Product Validations
S7252 Selinexor (KPT-330) Selinexor (KPT-330, ATG-010) is an orally bioavailable selective CRM1 inhibitor. Phase 2.
Gastroenterology, 2024, S0016-5085(24)00062-3
Nat Cell Biol, 2024, 10.1038/s41556-023-01338-y
Nat Commun, 2024, 15(1):1231
S7551 Piperlongumine Piperlongumine (PPLGM, Piplartine), a natural alkaloid from Piper longum L., increases the level of reactive oxygen species (ROS) and selectively kills cancer cells. It is a direct TrxR1 inhibitor with suppressive activity against gastric cancer and a novel inhibitor of CRM1; also an inhibitor of PI3K/Akt/mTOR in human breast cancer cells.
J Exp Clin Cancer Res, 2023, 42(1):118
Drug Des Devel Ther, 2023, 17:1387-1394
Nat Commun, 2022, 13(1):107
S8397 Eltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.
Gastroenterology, 2024, S0016-5085(24)00062-3
Sci Rep, 2023, 13(1):18554
Biomedicines, 2022, 10(9)2145
S7125 KPT-185 KPT-185 is a selective CRM1 inhibitor that induces growth inhibition and apoptosis in a panel of NHL cell lines with a median IC50 ~25 nM.
Cell Chem Biol, 2022, S2451-9456(22)00275-6
Oncotarget, 2020, 11(36):3371-3386
EMBO Rep, 2019, 20(11):e48150
S7707 Verdinexor (KPT-335) Verdinexor (KPT-335, ATG-527) is an orally bioavailable, selective XPO1/CRM1 inhibitor.
J Biomed Sci, 2022, 29(1):44
Cell Rep, 2022, 38(10):110472
NAR Cancer, 2022, 4(4):zcac033
S7251 KPT-276 KPT-276 is an orally bioavailable selective CRM1 inhibitor.
Elife, 2021, 10e67587
Front Oncol, 2020, 10:1424
Nat Commun, 2019, 10(1):3827
S7580 Leptomycin B Leptomycin B (LMB, CI 940, Elactocin, Mantuamycin, NSC 364372) is a potent antifungal antibiotic isolated from Streptomyces and acts as a specific inhibitor of the nuclear export factor CRM1. Leptomycin B rapidly induces cytotoxic effects in cancer cell lines via covalent inhibition of CRM1 with IC50 values of 0.1 nM–10 nM.
Cell Death Discov, 2023, 9(1):324
Commun Biol, 2022, 5(1):1391
S7252 Selinexor (KPT-330) Selinexor (KPT-330, ATG-010) is an orally bioavailable selective CRM1 inhibitor. Phase 2.
Gastroenterology, 2024, S0016-5085(24)00062-3
Nat Cell Biol, 2024, 10.1038/s41556-023-01338-y
Nat Commun, 2024, 15(1):1231
S7551 Piperlongumine Piperlongumine (PPLGM, Piplartine), a natural alkaloid from Piper longum L., increases the level of reactive oxygen species (ROS) and selectively kills cancer cells. It is a direct TrxR1 inhibitor with suppressive activity against gastric cancer and a novel inhibitor of CRM1; also an inhibitor of PI3K/Akt/mTOR in human breast cancer cells.
J Exp Clin Cancer Res, 2023, 42(1):118
Drug Des Devel Ther, 2023, 17:1387-1394
Nat Commun, 2022, 13(1):107
S8397 Eltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.
Gastroenterology, 2024, S0016-5085(24)00062-3
Sci Rep, 2023, 13(1):18554
Biomedicines, 2022, 10(9)2145
S7125 KPT-185 KPT-185 is a selective CRM1 inhibitor that induces growth inhibition and apoptosis in a panel of NHL cell lines with a median IC50 ~25 nM.
Cell Chem Biol, 2022, S2451-9456(22)00275-6
Oncotarget, 2020, 11(36):3371-3386
EMBO Rep, 2019, 20(11):e48150
S7707 Verdinexor (KPT-335) Verdinexor (KPT-335, ATG-527) is an orally bioavailable, selective XPO1/CRM1 inhibitor.
J Biomed Sci, 2022, 29(1):44
Cell Rep, 2022, 38(10):110472
NAR Cancer, 2022, 4(4):zcac033
S7251 KPT-276 KPT-276 is an orally bioavailable selective CRM1 inhibitor.
Elife, 2021, 10e67587
Front Oncol, 2020, 10:1424
Nat Commun, 2019, 10(1):3827
S7580 Leptomycin B Leptomycin B (LMB, CI 940, Elactocin, Mantuamycin, NSC 364372) is a potent antifungal antibiotic isolated from Streptomyces and acts as a specific inhibitor of the nuclear export factor CRM1. Leptomycin B rapidly induces cytotoxic effects in cancer cell lines via covalent inhibition of CRM1 with IC50 values of 0.1 nM–10 nM.
Cell Death Discov, 2023, 9(1):324
Commun Biol, 2022, 5(1):1391

Choose Selective CRM1 Inhibitors

Tags: CRM1 inhibitor|CRM1 agonist|CRM1 activator|CRM1 inducer|CRM1 antagonist|CRM1 signaling pathway|CRM1 assay kit